Concurrent detection of cognitive impairment and amyloid positivity with a multimodal machine learning-enabled digital cognitive assessment

Abstract Background Early identification of cognitive impairment and brain pathology associated with Alzheimer’s disease (AD) is essential to maximize benefits from lifestyle interventions and emerging pharmacologic disease-modifying treatments (DMT). Digital cognitive assessments (DCAs) can quickly...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ali Jannati, Karl Thompson, Claudio Toro-Serey, Joyce Gomes-Osman, Russell E. Banks, Connor Higgins, John Showalter, David Bates, Sean Tobyne, Alvaro Pascual-Leone
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2025-12-01
Colección:	Alzheimer’s Research & Therapy
Materias:	Alzheimer’s disease Mild cognitive impairment Dementia Digital cognitive assessment Machine learning Positron emission tomography
Acceso en línea:	https://doi.org/10.1186/s13195-025-01913-5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!